About
Lalo Flores is a Venture Partner at Scion Life Sciences and CEO of Flux Therapeutics, a Scion portfolio company. He has over 30 years of experience in the biopharmaceutical industry, beginning at Tularik (later acquired by Amgen) and holding senior R&D leadership roles at Merck and Johnson & Johnson. He co-founded Novira Therapeutics (acquired by Johnson & Johnson in 2015) and was founding CEO of Century Therapeutics, which he took public in 2021. He holds a doctorate in Biochemistry and Molecular Biology from Rutgers University and completed post-doctoral work at the Salk Institute.
Invests in
Biotech
Experience
- Stealth StartupChief Executive Officercurrent2023 — presentCambridge, Massachusetts, United States
- Century TherapeuticsChief Executive Officer2018 — 2023Greater Philadelphia Area
- Johnson & JohnsonEntrepreneur in Residence2018Spring House, PA
- Johnson & JohnsonVice President of R&D2015 — 2018Spring House, PA
- Novira TherapeuticsCo-founder, President and Chief Scientific Officer2009 — 2015Doylestown, PA
- MerckSenior Director2004 — 2008
- MerckDirector Antiviral Research1999 — 2004
- TularikScientist1992 — 1999
- The Salk InstitutePost Doctoral Fellow1991 — 1992
Education
- Rutgers UniversityPhD, Biochemistry
- Pontificia Universidad Católica de ValparaísoBS, Biology
Skills & more
Therapeutic Areas11HCV4Lifesciences5Immunology6Endocrinology14Drug Discovery28Target Identification6Clinical Research10Drug Development12Osteoporosis5Biotechnology20
Languages Spanish
From Lalo's professional profile.
Same school
Also attended Rutgers University86
Jigar RaythathaInvestor at Third Rock VenturesRobin LiInvestor at GGV CapitalGanesh PersadVice President & Chief Information Officer at Flare Capital PartnersMark FieldsInvestor at Alsop Louie PartnersBasil AlomaryPrincipal, Head of Research & Growth Strategy at StripesBrigitte KleineOperating Partner at Stripes
+ 80 more
Also attended Pontificia Universidad Católica de Valparaíso3
Shared employers
Also worked at Stealth Startup184
Andrew ChenGeneral Partner at Andreessen HorowitzErica VanInvestment Director at Intel CapitalHemamAdvisor at Clear VenturesHamish GarnettAssociate at Manta Ray VenturesFranz KoflerInvestor at Next Frontier CapitalGüimar Vaca SitticVenture Partner at FJ Labs
+ 178 more
Also worked at Johnson & Johnson128
Karthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesAaron PriceCEO, TechUnited at Tech Council VenturesJung Lee, PhDVenture Partner at Adelphi Ventures Management, Llc
+ 122 more
Also worked at Novira Therapeutics3
Also worked at Merck90
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAndrea van ElsasInvestor at Third Rock VenturesDavid KaufmanInvestor at Third Rock Ventures
+ 84 more
Colleagues at Scion Life Sciences
Aaron Kantoff
Managing Partner at Scion Life Sciences
Andreas Loew
Partner at Scion Life Sciences
Dave Katona
Head of Business Development & Investor Relations at Scion Life Sciences
Elliot Warner
Associate at Scion Life Sciences
Huw Nash
Venture Partner at Scion Life Sciences
Jeffrey Edelman
Partner at Scion Life Sciences
Megan Blewett
Principal at Scion Life Sciences
Romesh Subramanian
Venture Partner at Scion Life Sciences




































